NovelStem International Corp (NSTM)

[georgie18]

HOLL...21...NewStem Announces $4 million Seed InvestmentPress Release | 07/16/2018...

Authorized Shares
100,000,000
01/16/2018
Outstanding Shares
16,131,477
01/16/2018

https://www.otcmarkets.com/stock/HOLL/news/NewStem-Announces-4-million-Seed-Investment?id=198004

Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer of Haploid Stem Cell-Based Diagnostics to Predict Chemotherapy ResistancePress Release | 07/16/2018
Raises $1.925 Million to Support a $2 Million Initial Investment in NewStem Ltd.
Appoints New Board of Directors Led by Jan Loeb as Chairman
Forms New Leadership Team with Deep Healthcare Expertise
Plans to Rename Company NovelStem International Corp.

https://www.otcmarkets.com/stock/HOLL/news/Hollywood-Media-Completes-Transformational-Investment-in-NewStem-Israel-Based-Developer-of-Haploid-Stem-Cell-Based-Diagn?id=198002

Though HMC intends to provide periodic updates via press release as developments warrant, the company intends to remain “dark” for the foreseeable future, also to minimize overhead expense.

Mitchell Rubenstein – Director - Mr. Rubenstein co-founded and served as Chairman of HMC from its inception to June 2018, during which period the company returned approximately $37 million to shareholders in the form of dividends and share repurchases, including a tender offer. He founded Syfy Channel and numerous other media businesses.

Eric Richman – Director - Mr. Richman is a life science executive with significant leadership, operational and strategic experience from over 25 years in the field. He is currently a Venture Partner at Brace Pharma Capital and serves on the boards of LabConnect, F2G (board observer) and ADMA Biologics (NASDAQ: ADMA).